CPWM, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CPWM, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2022$288,000
-18.6%
5,345
-2.9%
0.03%
-15.6%
Q2 2022$354,000
-15.7%
5,507
+1.6%
0.03%
+6.7%
Q1 2022$420,000
-2.3%
5,419
+1.5%
0.03%
-11.8%
Q4 2021$430,0000.0%5,3400.0%0.03%
-15.0%
Q3 2021$430,000
-10.4%
5,340
-10.4%
0.04%
+11.1%
Q2 2021$480,000
-16.2%
5,962
-12.2%
0.04%
-26.5%
Q1 2021$573,000
+6.3%
6,793
+1.0%
0.05%0.0%
Q4 2020$539,000
+2.5%
6,723
+2.8%
0.05%
-10.9%
Q3 2020$526,000
-7.4%
6,543
-0.9%
0.06%
-15.4%
Q2 2020$568,000
+5.2%
6,602
-0.8%
0.06%
-17.7%
Q1 2020$540,000
-3.1%
6,6560.0%0.08%
+16.2%
Q4 2019$557,000
-4.3%
6,6560.0%0.07%
-10.5%
Q3 2019$582,000
+9.2%
6,656
+2.3%
0.08%
+2.7%
Q2 2019$533,000
+2.5%
6,508
+1.7%
0.07%
-1.3%
Q1 2019$520,000
+23.8%
6,401
+0.3%
0.08%
+8.7%
Q4 2018$420,000
-14.1%
6,381
+0.6%
0.07%
-1.4%
Q3 2018$489,000
+4.9%
6,343
+0.5%
0.07%
-1.4%
Q2 2018$466,000
+13.7%
6,3110.0%0.07%
+10.9%
Q1 2018$410,000
+34.9%
6,311
+34.1%
0.06%
-8.6%
Q4 2017$304,000
+3.1%
4,7060.0%0.07%
+1.4%
Q3 2017$295,000
-18.1%
4,706
-20.9%
0.07%
-15.9%
Q2 2017$360,000
+19.2%
5,948
+2.2%
0.08%
+18.8%
Q1 2017$302,000
+4.1%
5,822
-11.1%
0.07%
+6.2%
Q4 2016$290,000
-19.2%
6,549
-13.2%
0.06%
-17.7%
Q3 2016$359,000
+2.9%
7,549
-2.3%
0.08%
+1.3%
Q2 2016$349,000
-1.1%
7,725
-10.1%
0.08%
+1.3%
Q1 2016$353,000
+9.6%
8,589
+1.8%
0.08%
+20.3%
Q4 2015$322,000
+32.0%
8,441
+13.5%
0.06%
+20.8%
Q3 2015$244,000
-32.0%
7,438
+45.0%
0.05%
-38.4%
Q2 2015$359,0005,1280.09%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders